Sandra Patterson
Insightful analysis on the companies, events, and strategic shifts truly moving the world's markets.
About This Column
Sandra Patterson is a commentator and strategist who explores the intersection of corporate performance and market sentiment. Building on her background in analyzing high-stakes volatility, Sandra now delivers daily dispatches on the broad forces reshaping the 2026 investment landscape - from the impact of "AI fatigue" to the re-emergence of value stocks. With a reputation for providing a nuanced perspective on "the why behind the buy," she offers a unique lens on the catalysts that drive market momentum. Her writing is essential reading for anyone seeking to stay ahead of the curve in a complex and rapidly changing world.
Displaying items 1-20 of 824 in total
Beyond the Digital Clipboard: Agentic AI Tackles Construction's Margin Crisis
EasyA Hits $1.1B Valuation: Bootstrapped EdTech Plans 2027 Direct Listing
Luca Mining's C$211M Cozamin Coup: The Making of a Mid-Tier Copper Player
Kahua's Schedule Manager Targets the 45% Construction Overrun Gap
The Holiday Downtime Dilemma: Why 'Green' Dashboards Cost Retailers Millions
The Main Street TV Boom: How Local Businesses Are Hacking the Streaming Era
The Payer Equation: How Ardelyx’s Real-World Data Reshapes the GI Market
RHB Bank's CRM Overhaul: Defending the Incumbent Moat in an Era of AI Fatigue
How Calnex and VIAVI Are Teaming Up to Tackle the AI Network Bottleneck
The $1B Tuck-In: How Bluespring’s Latest Merger Redefines RIA Succession
When Elite Medicine Meets AI: Why Top Doctors Now Need Star Ratings
Elite Talent Shifts to Private Spine Centers Amid Robotic Surgery Boom
The GPU Revolution De-Risking Starlab's Single-Launch Space Station
Equity Bancshares Q3 Preview: M&A Strategy Meets Market Momentum
Shattering the Luxury Barrier: MI Windows Enters Scenic Door Market
Main Street Meets Wall Street: The Double-A Breakthrough in SBA Lending
The Why Behind the Buy: CJ Biomaterials' PHA Disrupts Packaging
From Rx to Pet Treats: Yuyu Pharma's AI-Driven Bet on Feline Health
Mastercard Backs Venly: The Quiet Rise of Stablecoin Infrastructure
